Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
| Operating expenses: | ||
| Research and development | $ 3,190,302 | $ 2,598,985 |
| General and administrative | 2,208,800 | 1,669,807 |
| Warrant inducement expense | 0 | 690,839 |
| Total operating expenses | 5,399,102 | 4,959,631 |
| Loss from operations | (5,399,102) | (4,959,631) |
| Other income (expense): | ||
| Interest income | 5,087 | 12,815 |
| Interest expense | (44,064) | (572,985) |
| Change in fair value of derivative liabilities | 7,000 | 338,000 |
| Change in fair value of warrant liabilities | 0 | 1,578,800 |
| Total other income (expense), net | (31,977) | 1,356,630 |
| Loss before income taxes | (5,431,079) | (3,603,001) |
| Income tax benefit | 0 | 0 |
| Net loss | $ (5,431,079) | $ (3,603,001) |
| Net loss per common share, basic (in dollars per share) | $ (0.03) | $ (0.09) |
| Net loss per common share, diluted (in dollars per share) | $ (0.03) | $ (0.09) |
| Weighted-average common shares, basic and diluted (in shares) | 211,280,867 | 41,162,296 |